Our patent is granted.Patent Number: 7744665
On September 2, 2025, our patent is granted.
Mesenchymal stromal cells (Mesenchymal Stem Cells; MSCs)* are anticipated to exert various therapeutic effects, including anti-inflammatory properties, and have been the subject of extensive research. However, the detailed molecular mechanisms and modes of action remain largely unclear.
Our company has elucidated that the conditioned medium containing secretions from MSCs regulates the expression of genes deeply associated with skin elasticity, firmness, and barrier function. Based on this discovery, we have obtained a patent.
This finding demonstrates, from the perspective of gene expression, that MSCs may be involved in skin wound healing, atopic dermatitis, and hair growth/regeneration. We consider this patent to be a highly significant foundational achievement.
Patent Overview:
Title of Invention: Gene Expression Regulator
Patent Number: 7744665
Patent Holder: Biomimetics Sympathies Inc.
Application Date: April 2nd, 2021
Registration Date: September 17th, 2025
*In accordance with the statement issued by the Japan Society for Regenerative Medicine on June 6, 2025, the conventional term “mesenchymal stem cells” has been replaced with “mesenchymal stromal cells,” with the former indicated in parentheses
https://www.jsrm.jp/news/news-16348